Sperm DNA fragmentation can be associated with infertility and pregnancy loss, but the 2024-amended AUA/ASRM guideline says not to use it routinely in the initial evaluation. It may become more relevant in selected situations such as recurrent pregnancy loss or repeated ART failure.
What the test measures
A standard semen analysis measures things such as concentration, motility, volume, and morphology. DNA fragmentation tests try to measure damage or breaks in sperm DNA.
Several different assays exist, and they do not all report or define abnormality in exactly the same way. That lack of standardization is one reason the result is harder to interpret than a simple “good/bad” number suggests.
Why clinics order it
Higher fragmentation has been associated in some studies with lower pregnancy rates or higher pregnancy-loss risk. Researchers have also studied relationships with age, heat exposure, smoking, infection, varicocele, abstinence interval, medications, and oxidative stress.
The important question is whether testing actually changes management in a way proven to improve outcomes.
What the AUA/ASRM guideline says
The guideline, amended in 2024, recommends against sperm DNA fragmentation analysis in the initial evaluation of the infertile couple. It notes the lack of prospective studies showing that couples who undergo this testing have better outcomes because the test changed their care.
For recurrent pregnancy loss, however, the same guideline says male evaluation should include consideration of sperm DNA fragmentation.
What about failed IVF?
The guideline notes that testing may be useful in selected males in couples undergoing IVF with repeated failure. Some clinicians may consider testicular sperm in men with very high fragmentation, but the evidence supporting that strategy remains limited and controversial.
That is not remotely the same as saying every man with infertility needs a DNA fragmentation panel before the first treatment cycle.
Why the cutoff can be slippery
Different assays use different methods and thresholds. A result that reads “high” on one platform is not always directly interchangeable with another.
Before paying for the test, ask what your clinic would do differently at 15%, 25%, 35%, or whatever threshold its lab uses.
Start with the basic male evaluation
AUA/ASRM recommends reproductive history plus one or more semen analyses in the initial male evaluation. If parameters are abnormal, evaluation by a male reproductive expert is appropriate.
That history and examination can uncover issues a DNA fragmentation report cannot: medications, exogenous testosterone use, varicocele, sexual dysfunction, obstruction, hormonal disorders, prior surgery, infections, and other medical conditions.
Use DNA fragmentation as a targeted second-line question, not a default first test.
- Usually discussed when
- Recurrent pregnancy loss, repeated ART failure, or a male reproductive specialist believes the result would change management.
- Main upside
- May add information not captured by concentration, motility, and morphology in selected cases.
- Main tradeoff
- Assays and cutoffs vary, evidence that routine testing improves outcomes is limited, and the result can trigger expensive interventions.
- Why are you ordering this test in my specific case?
- Which assay does your lab use and what threshold changes treatment?
- What would you do differently if the result is high?
Frequently asked questions
Is sperm DNA fragmentation part of a normal semen analysis?
No. It is a separate advanced sperm-function test.
Should it be ordered with the first infertility workup?
AUA/ASRM recommends against routine sperm DNA fragmentation testing in the initial evaluation.
Is it useful after recurrent miscarriage?
The male infertility guideline recommends considering male evaluation including sperm DNA fragmentation in couples with recurrent pregnancy loss.